Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 23, 2018
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody-Drug ConjugatesEshita Khera, Greg M ThurberMolecular Imaging and Biology|September 3, 2010
Quantitating antibody uptake in vivo: conditional dependence on antigen expression levelsGreg M Thurber, Ralph WeisslederMolecular Imaging and Biology|July 22, 2015
Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular ImagingLiang Zhang, Greg M ThurberScientific Reports|May 10, 2022
Design of high avidity and low affinity antibodies for in situ control of antibody drug conjugate targetingReginald Evans, Greg M ThurberCell Chemical Biology|January 18, 2020
Severing Ties: Quantifying the Payload Release from Antibody Drug ConjugatesAnna Kopp, Greg M ThurberJournal of Theoretical Biology|September 15, 2012
A mechanistic compartmental model for total antibody uptake in tumorsGreg M Thurber, K Dane WittrupCancer Research|May 3, 2008
Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroidsGreg M Thurber, K Dane WittrupPharmaceutics|February 9, 2020
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio ImagingIan Nessler, Cornelius Cilliers, Greg M ThurberTrends in Biochemical Sciences|December 20, 2018
Hitting Undruggable Targets: Viewing Stabilized Peptide Development through the Lens of Quantitative Systems PharmacologyLydia Atangcho, Tejas Navaratna, Greg M ThurberTrends in Pharmacological Sciences|August 30, 2021
Key metrics to expanding the pipeline of successful antibody-drug conjugatesIan Nessler, Bruna Menezes, Greg M ThurberPageof 7